Health: Public Affairs & Public Relations Support
Brevia Health provides straightforward public affairs and communications advice and support to organisations operating in the highly regulated UK healthcare sector. The consultancy brings together experts who have held senior roles in NICE, MHRA, Government Health teams, Opposition Health teams and across industry. We use this rounded perspective to bring new thinking and well-developed proposals across a wide range of policy areas.
As the UK emerges from the far-reaching consequences of COVID-19 and BREXIT, it is clear that the healthcare system has changed, and leaders are open to new approaches. Never has there been a better time for organisations to make practical, thought-through proposals which show broad-based benefits.
The much anticipated publication of the NHS Commercial Framework for New Medicines in 2021 represents a significant milestone for the pharmaceutical industry. It outlines the purpose and principles on which NHS commercial medicines activity will be based, defines the roles and responsibilities of those involved in commercial medicines activity and details how pharmaceutical companies can engage with the NHS.
Brevia Health supports global multi-nationals, innovative start-ups, providers, and charities. Our experience includes supporting companies to win IT contracts with the NHS through to gaining approval for medicines with NICE. We have also worked in areas such as in vitro diagnostics, medical devices, and genomics, as well as delivering programmes involving policy and stakeholder research, political and media monitoring, stakeholder engagement, event management, media relations, Party Conferences, and Select Committee training.
MEET THE TEAM
CLIENT EXPERIENCE
TESTIMONIALS
NEWS
Shaping the Future of CfDs: Key Reforms in AR7 Consultation
With the DESNZ consultation on AR7 closing on 21 March 2025, Brevia Energy examines the key proposals that could shape the future of the Contracts for Difference (CfD) regime. From relaxed eligibility requirements for offshore wind, to extended contract terms and new capacity ambitions, these changes could significantly impact the renewable energy sector. Businesses and investors must engage with the consultation to ensure their interests are represented in the evolving energy landscape.
What does the Seventh Carbon Budget mean for the future of hydrogen?
The Climate Change Committee recently published its Seventh Carbon Budget, outlining the UK’s strategic framework for achieving significant emissions reductions over the coming decades. A key takeaway is the downgrading of the CCC’s view on hydrogen for home compared with the Sixth Carbon Budget published in 2020. In this article, Brevia reviews the CCC’s positioning on heat in the Seventh Carbon Budget compared to the Sixth Carbon Budget.
Future of UK Electricity Pricing: Is Zonal Pricing Inevitable?
With a decision on the Review of the Electricity Market Arrangements (REMA) expected imminently, and the intensity around the debate on zonal pricing growing, Brevia’s energy team takes a look at the latest developments, assessing implications, key considerations and expected timelines for businesses to consider in navigating this potential transition.
WORK WITH US
A track record in delivering results
Brevia Health delivers tailored support to businesses and charities operating in the health sector. Our three-step process offers a straightforward approach to delivering crucial intelligence, strategic advice and stakeholder engagement.
